FEB 13, 2020 7:40 PM PST

Study of Early-Onset Parkinson's Reveals Potential Therapeutic

WRITTEN BY: Carmen Leitch

Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising. Symptoms include tremors, rigid muscles, slow movement, and loss of balance, which all get worse over time. The neurodegenerative disorder happens when neurons in the brain that make a signaling molecule called dopamine start malfunctioning or dying. The reason for that neuronal dysfunction and death is still unknown.

Image credit: Pixabay

New research reported in Nature Medicine has focused on the ten percent of Parkinson's patients that are diagnosed from the ages of 21 to 50, which is younger than typical patients, who tend to be diagnosed when they are over 60.

"Young-onset Parkinson's is especially heartbreaking because it strikes people at the prime of life," said study co-author Michele Tagliati, MD, director of the Movement Disorders Program, vice-chair, and professor in the Department of Neurology at Cedars-Sinai. "This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals."

The researchers applied the Nobel-prize winning technique for generating stem cells from adult blood cells for this work. They obtained the cells from the early-onset Parkinson's patients, then used the patient-derived induced pluripotent stem cells they created to make neurons that produce dopamine. They were then able to study these patient-derived cells in the lab to assess their physiology.

"Our technique gave us a window back in time to see how well the dopamine neurons might have functioned from the very start of a patient's life," noted the senior author of the study Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and a professor of Biomedical Sciences and Medicine at Cedars-Sinai.

Two critical cellular abnormalities were identified by the scientists; a protein called alpha-synuclein was building up, which is similar to what's seen in Parkinson's disease, and cellular recycling centers known as lysosomes were not functioning properly. This lysosomal dysfunction may be causing alpha-synuclein accumulation.

"What we are seeing using this new model are the very first signs of young-onset Parkinson's," said Svendsen. "It appears that dopamine neurons in these individuals may continue to mishandle alpha-synuclein over a period of 20 or 30 years, causing Parkinson's symptoms to emerge."

The researchers also tested drugs using the cells they engineered to see if any could stop or reverse the dysfunctions. One drug called PEP005 that is already used to treat skin precancers was able to lower the high alpha-synuclein levels in the cells as well as in a mouse model.

The team wants to learn more about how this drug might be used to prevent or treat early-onset Parkinson's disease, and whether the abnormalities they identified hold true for other types of Parkinson's.

Sources: Science Daily via Cedars-Sinai Medical Center, Nature Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 11, 2021
Microbiology
Small RNAs are Influential in Bacteria, Including Pathogens Like V. Cholerae
OCT 11, 2021
Small RNAs are Influential in Bacteria, Including Pathogens Like V. Cholerae
Like other organisms, bacteria have to take nutrients up from the environment and use them in various metabolic processe ...
OCT 14, 2021
Cell & Molecular Biology
Cutting Edge Tools Change Our View of the Nuclear Pore Complex
OCT 14, 2021
Cutting Edge Tools Change Our View of the Nuclear Pore Complex
There are many intricate molecular machines that perform essential functions, and this work has called a method used to ...
NOV 01, 2021
Cell & Molecular Biology
Is This Closed Barrier Why Psychiatric & Bowel Disorders are Linked?
NOV 01, 2021
Is This Closed Barrier Why Psychiatric & Bowel Disorders are Linked?
Inflammatory bowel disease (IBD) is a term that describes chronic gut inflammation and includes ulcerative colitis and C ...
NOV 11, 2021
Immunology
Malaria Researchers Make a Surprising Antibody Find
NOV 11, 2021
Malaria Researchers Make a Surprising Antibody Find
Researchers looking into the immunology of malaria infections have made an unexpected find that could ultimately lead to ...
NOV 26, 2021
Cell & Molecular Biology
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
NOV 26, 2021
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
Identical twins carry the same genome in their cells, which makes them powerful subjects in the study of human disease. ...
NOV 28, 2021
Cell & Molecular Biology
Scientists Gain Insight Into How Bacteria Become Resistant to Drugs
NOV 28, 2021
Scientists Gain Insight Into How Bacteria Become Resistant to Drugs
Bacteria can swap genetic material with one another easily; one way they do it is a process called bacterial conjugation ...
Loading Comments...